Overview
Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease
Written by: Paul M Ridker, M.D.A. Michael Lincoff, M.D.Nikolaus Marx, M.D.Ann Marie Navar, M.D.Naveed Sattar, M.B., Ch.B.Katherine R. Tuttle, M.D.Matthew Budoff, M.D.Morten Böttcher, M.D.Matthew A. Cavender, M.D.Robin P. Choudhury, D.M.Jan H. Cornel, M.D.Grzegorz Gajos, M.D.Issei Komuro, M.D.K.M.K. Reddy Parvathareddy, M.D.Roberto Pontremoli, M.D.José Francisco Kerr Saraiva, M.D.Iana I. Simova, M.D.Lance A. Sloan, M.D.Alejandro López-Suárez, M.D.Yi-Da Tang, M.D.Lale Tokgözoğlu, M.D.Nqoba Tsabedze, M.D.Konstantinos Tsioufis, M.D.Subodh Verma, M.D.Mathias Vrolix, M.D.Andreas Andersen, Ph.D.Florian M.M. Baeres, M.D.Kathrine Ekström, M.D.Mads D.M. Engelmann, M.D.Sofia Gerward, M.D.G. Kees Hovingh, M.D.Anders Hvelplund, M.D.Vlado Perkovic, M.B., B.S.

